NCT06754306

Brief Summary

This randomized clinical trial aims to evaluate the dynamic effects of various dietary interventions on visceral fat and biochemical markers among healthy adults. Participants aged 18-35 years with a normal body mass index (BMI 18.5-23.9) will be recruited from the community. Exclusion criteria include metabolic diseases, unstable weight, medication use, or pregnancy. Participants will be randomly assigned to one of seven groups: 1) balanced diet (100% energy), 2) time-restricted eating (16+8, 100% energy), 3) time-restricted eating (16+8, 75% energy), 4) alternate-day fasting (75% energy), 5) 5+2 fasting (75% energy), 6) low-calorie diet (75% energy), and 7) very low-calorie diet (45% energy). The intervention consists of a 1-week baseline phase, a 4-week dietary intervention phase, and a 28-week recovery phase. Primary outcomes include changes in visceral fat area, while secondary outcomes include body composition, cardiovascular health indicators (e.g., blood pressure, cholesterol), inflammation markers, and liver/kidney function. Biological samples (blood, urine, and feces) will be collected at multiple time points to facilitate multi-omics analyses, including proteomics, metabolomics, metagenomics, and DNA methylation. The study aims to compare the short-term effects of different dietary interventions and explore underlying biological mechanisms. Findings will provide evidence for public health policies and dietary guidelines related to weight management and metabolic health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 25, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2025

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

December 18, 2024

Last Update Submit

November 23, 2025

Conditions

Keywords

Dietary InterventionRandomized Controlled TrialIntermittent FastingCaloric Restriction

Outcome Measures

Primary Outcomes (1)

  • Change in Visceral Fat Area over the Course of the Dietary Intervention

    Visceral fat area will be measured using the InBody770 bioelectrical impedance analysis (BIA) device.

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32

Secondary Outcomes (31)

  • Change in Body Weight over the Course of the Dietary Intervention

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32

  • Change in Waist Circumference over the Course of the Dietary Intervention

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32

  • Change in Hip Circumference over the Course of the Dietary Intervention

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32

  • Body height at Baseline

    Baseline only

  • Change in Body Mass Index (BMI) over the Course of the Dietary Intervention

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32

  • +26 more secondary outcomes

Study Arms (7)

Balanced diet group

EXPERIMENTAL

Daily intake of 100% energy requirements, adjusted individually based on each participant's basal metabolic rate (BMR) and activity level.

Other: Balanced diet (100% energy)

16+8 time-restricted eating group (100% energy)

EXPERIMENTAL

Participants will consume 100% energy within an 8-hour eating window and fast for the remaining 16 hours.

Other: 16+8 time-restricted eating group (100% energy)

16+8 time-restricted eating group (75% energy)

EXPERIMENTAL

Participants will consume 75% of their energy requirements within the 8-hour eating window.

Other: 16+8 time-restricted eating group (75% energy)

Alternate-day fasting group (75% energy)

EXPERIMENTAL

Participants alternate between "feeding days" (125% energy requirements) and "fasting days" (25% energy requirements).

Other: Alternate-day fasting group (75% energy)

5+2 intermittent fasting group (75% energy)

EXPERIMENTAL

Participants consume 95% energy requirements for 5 consecutive days and 25% energy requirements for 2 fasting days.

Other: 5+2 intermittent fasting group (75% energy)

Low-calorie diet group (75% energy)

EXPERIMENTAL

Participants will reduce daily caloric intake to 75% of energy requirements, consumed evenly across three meals.

Other: Low-calorie diet group (75% energy)

Very low-calorie diet group (45% energy)

EXPERIMENTAL

Participants will reduce daily caloric intake to 45% of energy requirements (\~800 kcal/day)

Other: Very low-calorie diet group (45% energy)

Interventions

Daily intake of 100% energy requirements, adjusted individually based on each participant's basal metabolic rate (BMR) and activity level.

Balanced diet group

Participants will consume 100% energy within an 8-hour eating window and fast for the remaining 16 hours.

16+8 time-restricted eating group (100% energy)

Participants will consume 75% of their energy requirements within the 8-hour eating window.

16+8 time-restricted eating group (75% energy)

Participants alternate between "feeding days" (125% energy requirements) and "fasting days" (25% energy requirements).

Alternate-day fasting group (75% energy)

Participants consume 95% energy requirements for 5 consecutive days and 25% energy requirements for 2 fasting days.

5+2 intermittent fasting group (75% energy)

Participants will reduce daily caloric intake to 75% of energy requirements, consumed evenly across three meals.

Low-calorie diet group (75% energy)

Participants will reduce daily caloric intake to 45% of energy requirements (\~800 kcal/day)

Very low-calorie diet group (45% energy)

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants aged 18-35 years.
  • BMI between 18.5 and 23.9.
  • Willing to voluntarily sign the informed consent form and comply with group assignments and intervention protocols.

You may not qualify if:

  • Diagnosed with metabolic diseases such as hypertension, diabetes, or dyslipidemia.
  • Diagnosed with uncontrolled psychiatric disorders.
  • Diagnosed with severe underlying diseases, such as renal failure, heart failure, or cancer.
  • Currently taking medications that may affect study outcomes (e.g., antihypertensive, antidiabetic, or lipid-lowering drugs).
  • Women in the perimenopausal stage or with irregular menstrual cycles.
  • Pregnant women.
  • Current smokers.
  • Unstable weight within the past three months (fluctuations exceeding 4 kg).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Public Health, Shanghai Jiao Tong University, Shanghai, China

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Intermittent Fasting

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Study Officials

  • Hui Wang, PhD

    School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Professor, and Doctor

Study Record Dates

First Submitted

December 18, 2024

First Posted

December 31, 2024

Study Start

August 25, 2024

Primary Completion

June 9, 2025

Study Completion

June 9, 2025

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

We acknowledge the importance of data sharing for scientific advancement; however, due to the absence of a predefined data sharing mechanism in our study design and the need to prioritize participant confidentiality, we currently do not have a plan to share individual participant data (IPD). We remain open to exploring future opportunities to share aggregate data or collaborate with interested researchers within an ethically appropriate framework.

Locations